Your browser doesn't support javascript.
loading
A caveolae-targeted L-type Ca²+ channel antagonist inhibits hypertrophic signaling without reducing cardiac contractility.
Makarewich, Catherine A; Correll, Robert N; Gao, Hui; Zhang, Hongyu; Yang, Baohua; Berretta, Remus M; Rizzo, Victor; Molkentin, Jeffery D; Houser, Steven R.
Affiliation
  • Makarewich CA; Cardiovascular Research Center and Department of Physiology, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Circ Res ; 110(5): 669-74, 2012 Mar 02.
Article in En | MEDLINE | ID: mdl-22302787

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiomyopathy, Hypertrophic / Calcium Channel Blockers / Signal Transduction / Calcium Channels, L-Type / Caveolae / Myocardial Contraction Type of study: Prognostic_studies Limits: Animals Language: En Journal: Circ Res Year: 2012 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiomyopathy, Hypertrophic / Calcium Channel Blockers / Signal Transduction / Calcium Channels, L-Type / Caveolae / Myocardial Contraction Type of study: Prognostic_studies Limits: Animals Language: En Journal: Circ Res Year: 2012 Type: Article Affiliation country: United States